Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells

  • Authors:
    • Suparata Kiartivich
    • Ying Wei
    • Jiaqi Liu
    • Rungtip Soiampornkul
    • Mihui Li
    • Hongying Zhang
    • Jingcheng Dong
  • View Affiliations

  • Published online on: Thursday, February 16, 2017
  • DOI: 10.3892/ol.2017.5746
0

Abstract

Scutellaria baicalensis (SB; Chinese name, huangqin) is widely used in Chinese medicine as a traditional adjuvant in the chemotherapy of lung and liver cancer. Baicalein is one of the bioactive flavonoid components isolated from the root of SB. The present study aimed to observe the effect of baicalein, in combination with platin-based systemic chemotherapy (cisplatin), on cytotoxicity and apoptosis of human A549 lung cancer cells. The cell cultures were treated with baicalein, cisplatin, or a combination of the two. Cell viability and cytotoxicity was assayed by XTT, and cell apoptosis was measured by flow cytometry. The apoptosis‑associated proteins were detected by western blot analysis. The cytokines in the culture supernatant were detected by ELISA. The present study revealed that cisplatin and the baicalein-cisplatin combination inhibited viability and promoted cytotoxicity of A549 cells. Cisplatin, baicalein and baicalein-cisplatin combination treatments were effective in the promotion of apoptosis of A549 cells. Baicalein and baicalein-cisplatin combination treatments also inhibited B cell lymphoma‑2 (Bcl‑2) and increased Bcl‑2‑associated X protein (Bax) expression. Additionally, cisplatin, baicalein and the baicalein‑cisplatin combination promoted caspase‑3 expression. Furthermore, the baicalein‑cisplatin combination suppressed the secretion of interleukin‑6, and baicalein and the combination of baicalein cisplatin decreased the secretion of tumor necrosis factor‑α of A549 cells. The present study concluded that baicalein combined with cisplatin induced cytotoxicity and apoptosis of A549 cells, and such activity may be associated with the regulation of Bcl‑2, Bax and caspase‑3, indicating a promising alternative method for lung cancer.

Related Articles

Journal Cover

Print ISSN: 1792-1074
Online ISSN:1792-1082

2015 Impact Factor: 1.482
Ranked #97/211 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Kiartivich, S., Wei, Y., Liu, J., Soiampornkul, R., Li, M., Zhang, H., & Dong, J. (1899). Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells. Oncology Letters, 0, 0-0. http://dx.doi.org/10.3892/ol.2017.5746
MLA
Kiartivich, S., Wei, Y., Liu, J., Soiampornkul, R., Li, M., Zhang, H., Dong, J."Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells". Oncology Letters 0.0 (1899): 0-0.
Chicago
Kiartivich, S., Wei, Y., Liu, J., Soiampornkul, R., Li, M., Zhang, H., Dong, J."Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells". Oncology Letters 0, no. 0 (1899): 0-0. http://dx.doi.org/10.3892/ol.2017.5746